TCL Archive In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR December 2, 1977
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP June 20, 2014
